Conversely, miR-221/222 downregulates PTEN expression by directly targeting PTEN mRNA in diseases such as NSCLC, hepatocellular carcinoma (HCC), and TNF-related apoptosis-inducing ligand (TRAIL)-induced cell death [43]. The gene discussed is PTEN; the disease is non-small cell lung carcinoma.